Behavioral Health Business August 28, 2024
The behavioral health industry generally isn’t as entwined and reliant on the pharmaceutical industry as the rest of the health care industry.
This creates a wide open space for innovative approaches to care. But there are powerful reasons behind why that space exists. Even so, as things stand today, the addiction treatment industry has the greatest direct interaction with the pharmaceutical industry.
With those strong connections — illustrated by opioid treatment programs (OTPs), which are centered on the oversight of methadone — there are gaps that aren’t being filled from a pharmaceutical perspective that operators need to address.
For example, there are no approved pharmaceuticals meant to specifically treat stimulant abuse, such as methamphetamine use disorder. However, there isn’t exactly...
Today's Sponsors
Today's Sponsor